Aged G Protein-Coupled Receptor Kinase 3 (Grk3)-Deficient Mice Exhibit Enhanced Osteoclastogenesis and Develop Bone Lesions Analogous to Human Paget’s Disease of Bone
暂无分享,去创建一个
Justin T. Gladman | S. Ralston | Sachin E. Wani | J. Bowser | Yinshi Ren | M. Hilton | T. Tarrant | A. Eudy | Kathryn Berg | E. Rabjohns | K. Hurst | Arin Ghosh | R. Rampersad | Jaime M. Brozowski | A. Mirando | Hyun Ho Lee | K. Berg | S. Wani
[1] Christopher C. Overall,et al. Senescent cells perturb intestinal stem cell differentiation through Ptk7 induced noncanonical Wnt and YAP signaling , 2023, Nature Communications.
[2] M. Yamauchi,et al. Optineurin regulates NRF2-mediated antioxidant response in a mouse model of Paget’s disease of bone , 2023, Science advances.
[3] Huajun Chen,et al. De novo analysis of bulk RNA-seq data at spatially resolved single-cell resolution , 2022, bioRxiv.
[4] C. Rubin,et al. G protein-coupled receptor kinase 3 modulates mesenchymal stem cell proliferation and differentiation through sphingosine-1-phosphate receptor regulation , 2021, Stem cell research & therapy.
[5] T. Tarrant,et al. Paget’s Disease of Bone: Osteoimmunology and Osteoclast Pathology , 2021, Current Allergy and Asthma Reports.
[6] C. Chung,et al. Loss of CD73 shifts transforming growth factor-β1 (TGF-β1) from tumor suppressor to promoter in endometrial cancer. , 2021, Cancer letters.
[7] Stuart Maudsley,et al. G Protein-Coupled Receptor Systems and Their Role in Cellular Senescence , 2019, Computational and structural biotechnology journal.
[8] Anna Teti,et al. Immune Function and Diversity of Osteoclasts in Normal and Pathological Conditions , 2019, Front. Immunol..
[9] P. Xue,et al. Global deletion of Optineurin results in altered type I IFN signaling and abnormal bone remodeling in a model of Paget’s disease , 2019, Cell Death & Differentiation.
[10] Wanli W. Smith,et al. Overview of RAW264.7 for osteoclastogensis study: Phenotype and stimuli , 2019, Journal of cellular and molecular medicine.
[11] M. Rouleau,et al. A Novel Reliable and Efficient Procedure for Purification of Mature Osteoclasts Allowing Functional Assays in Mouse Cells , 2018, Front. Immunol..
[12] S. Ralston,et al. Zoledronic acid prevents pagetic-like lesions and accelerated bone loss in the p62P394L mouse model of Paget's disease , 2018, Disease Models & Mechanisms.
[13] Michael C. Ostrowski,et al. Enhancer variants reveal a conserved transcription factor network governed by PU.1 during osteoclast differentiation , 2018, Bone Research.
[14] A. de Bruin,et al. Hypoxia negatively affects senescence in osteoclasts and delays osteoclastogenesis , 2018, Journal of cellular physiology.
[15] I. Kalajzic,et al. Increased chemotaxis and activity of circulatory myeloid progenitor cells may contribute to enhanced osteoclastogenesis and bone loss in the C57BL/6 mouse model of collagen‐induced arthritis , 2016, Clinical and experimental immunology.
[16] Y. Truong,et al. G Protein Coupled Receptor Kinase 3 Regulates Breast Cancer Migration, Invasion, and Metastasis , 2016, PloS one.
[17] Jason A Inzana,et al. NOTCH signaling in skeletal progenitors is critical for fracture repair. , 2016, The Journal of clinical investigation.
[18] P. Cohen,et al. Optineurin Negatively Regulates Osteoclast Differentiation by Modulating NF-κB and Interferon Signaling: Implications for Paget’s Disease , 2015, Cell reports.
[19] Shi Wei,et al. The IVVY Motif and Tumor Necrosis Factor Receptor-associated Factor (TRAF) Sites in the Cytoplasmic Domain of the Receptor Activator of Nuclear Factor κB (RANK) Cooperate to Induce Osteoclastogenesis* , 2015, The Journal of Biological Chemistry.
[20] M. Murad,et al. Bone turnover markers in Paget’s disease of the bone: A Systematic review and meta-analysis , 2015, Osteoporosis International.
[21] T. Yuen,et al. Bisphosphonates inactivate human EGFRs to exert antitumor actions , 2014, Proceedings of the National Academy of Sciences.
[22] I. Reid,et al. Paget's disease of bone: an endocrine society clinical practice guideline. , 2014, The Journal of clinical endocrinology and metabolism.
[23] D. Galson,et al. Pathobiology of Paget's Disease of Bone , 2014, Journal of bone metabolism.
[24] T. Tarrant,et al. Targeting the Molecular and Cellular Interactions of the Bone Marrow Niche in Immunologic Disease , 2014, Current Allergy and Asthma Reports.
[25] D. Siderovski,et al. G protein‐coupled receptor kinase‐3‐deficient mice exhibit WHIM syndrome features and attenuated inflammatory responses , 2013, Journal of leukocyte biology.
[26] J. Walsh,et al. New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget's disease of bone. , 2013, Endocrine reviews.
[27] S. Ralston,et al. A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice. , 2011, Human molecular genetics.
[28] Mitch Dowsett,et al. Current and emerging biomarkers in breast cancer: prognosis and prediction. , 2010, Endocrine-related cancer.
[29] J. Kieft,et al. Elevated histone expression promotes life span extension. , 2010, Molecular cell.
[30] Stuart L Schreiber,et al. Reduced histone biosynthesis and chromatin changes arising from a damage signal at telomeres , 2010, Nature Structural &Molecular Biology.
[31] William D Fraser,et al. Genome wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget’s disease of bone , 2010, Nature Genetics.
[32] I. Reid,et al. Pathogenesis and management of Paget's disease of bone , 2008, The Lancet.
[33] A. Su,et al. Expression analysis of G Protein-Coupled Receptors in mouse macrophages , 2008, Immunome research.
[34] H. Schiöth,et al. Structural diversity of G protein-coupled receptors and significance for drug discovery , 2008, Nature Reviews Drug Discovery.
[35] S. Ralston,et al. Identification of Sex‐Specific Associations Between Polymorphisms of the Osteoprotegerin Gene, TNFRSF11B, and Paget's Disease of Bone , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[36] D. Dempster,et al. Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease. , 2007, The Journal of clinical investigation.
[37] A. Rapado,et al. Clinical usefulness of serum tartrate-resistant acid phosphatase in paget's disease of bone: Correlation with other biochemical markers of bone demodelling , 2007, Calcified Tissue International.
[38] H. Aguila,et al. Identification of Multiple Osteoclast Precursor Populations in Murine Bone Marrow , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[39] L. Hocking,et al. SQSTM1 and Paget’s Disease of Bone , 2004, Calcified Tissue International.
[40] L. Hocking,et al. Susceptibility to Paget's Disease of Bone Is Influenced by a Common Polymorphic Variant of Osteoprotegerin , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[41] R. Spurney. Regulated Expression of G Protein-Coupled Receptor Kinases (GRK’s) and β-Arrestins in Osteoblasts , 2003, Calcified Tissue International.
[42] Jacques P. Brown,et al. Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. , 2002, American journal of human genetics.
[43] S. C. Garner,et al. Anabolic effects of a G protein-coupled receptor kinase inhibitor expressed in osteoblasts. , 2002, The Journal of clinical investigation.
[44] A. Scillitani,et al. Gender Differences in Serum Markers of Bone Resorption in Healthy Subjects and Patients with Disorders Affecting Bone , 2002, Osteoporosis International.
[45] R. Spurney,et al. Domains of the parathyroid hormone (PTH) receptor required for regulation by G protein-coupled receptor kinases (GRKs). , 2001, Biochemical pharmacology.
[46] Robert J. Lefkowitz,et al. G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.
[47] Marc G. Caron,et al. G Protein-coupled Receptor Kinase 3 (GRK3) Gene Disruption Leads to Loss of Odorant Receptor Desensitization* , 1997, The Journal of Biological Chemistry.
[48] R. Deulofeu,et al. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.